CARLSBAD, Calif.--(BUSINESS WIRE)--ArtVentive Medical Group, Inc. (OTCBB: AVTD) announced today enrollment in the ongoing ArtVentive EOS™ Endoluminal Occlusion System, OCCLUDE post-market surveillance study.
The study is dedicated to further advancement of use of the ArtVentive EOS™ embolization device in treating venous and arterial cases where the precise placement and immediate, efficient vessel embolization are paramount.
